#SteerBio
RBL LLC Launches SteerBio, Pioneering Therapy for Lymphedema with $18.2 Million Federal Funding#USA#Houston#Lymphedema#RBL_LLC#SteerBio
RBL LLC Launches SteerBio, Pioneering Therapy for Lymphedema with $18.2 Million Federal Funding
RBL LLC's new spin-off, SteerBio, has launched with $18.2 million in federal funding for a novel therapy targeting lymphedema, aiming to change patient lives.
third-news.com
March 5, 2026 at 1:15 PM